Who is sponsoring NCT00882960?

NCT00882960 is sponsored by Genesys.

What condition does NCT00882960 study?

NCT00882960 studies Trauma, Pain.

What drugs are being tested in NCT00882960?

Interventions: intravenous fentanyl, intra-nasal fentanyl.

What is the status of NCT00882960?

NCT00882960 is currently UNKNOWN.

Last reviewed 2011-05-03 · How we verify

Atomization of Fentanyl: A Randomized Comparison Study of Intranasal Versus Intravenous Fentanyl for Pre-hospital Pain Management

NCT00882960 Phase 4 UNKNOWN

Goal of the research will be to demonstrate a reduction in reported pain following the atomization and intra-nasal administration of Fentanyl versus the reduction in pain achieved from intravenous Fentanyl. It is hypothesized that pain should be reduced following fentanyl administration using the intra-nasal atomization equal to the intravenous delivery.

Details

Lead sponsor	Genesys
Phase	Phase 4
Status	UNKNOWN
Enrolment	500
Start date	2009-04
Completion	2012-04

Conditions

Trauma
Pain

Interventions

intravenous fentanyl
intra-nasal fentanyl

Primary outcomes

The primary measure will be the change recorded in patients subjective pain using a standardized scale — Pain will be assessed at 5 and 10 minutes post administration of Fentanyl

Countries

United States